Exagen

XGN13F as of Jun 30, 2026 · next update ~Nov 14

Limited coverage

Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.

Who's buying XGN

Top funds mostly added to Exagen in Q2 (Apr⁠–⁠Jun)

Buying:

Funds1InsidersCongress

Top funds
1 of 1 bought more, 0 sold some. Largest: First Eagle Investment Management, $1.4M (0% of its portfolio).
Insiders
1 insider bought, 5 sales in 12 months.
Congress
No trades disclosed in the last 12 months.

1 fund$1.4M held0.0% avg. weightQ2: 1 bought / 0 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 12 filings

Net buying$3.15M

Date	Insider	Type	Shares	Price	Value
Oct 19, 2026	Jorey Chernett 10% Owner	Bought	14,000	$7.46	$104K
Oct 16, 2026	John Aballi President & CEO	Sold	34,294	$7.87	$270K
Sep 1, 2026	Jeffrey G. Black CFO	Sold	20,614	$7.22	$149K
Mar 3, 2026	John Aballi President & CEO	Sold	15,698	$3.62	$57K
Feb 24, 2026	John Aballi President & CEO	Sold	11,430	$3.61	$41K
Feb 24, 2026	Jeffrey G. Black CFO	Sold	1,584	$3.61	$6K
Oct 16, 2025	John Aballi President & CEO	Sold	31,787	$11.82	$376K
Sep 2, 2025	Jeffrey G. Black CFO	Sold	20,466	$9.79	$200K
Mar 25, 2025	Nmsic Co-Investment Fund, L.P. 10% Owner	Sold	350,000	$3.30	$1.16M
Nov 20, 2024	Nmsic Co-Investment Fund, L.P. 10% Owner	Sold	200,000	$3.30	$660K
Nov 15, 2024	Jeffrey G. Black CFO	Bought	22,298	$2.98	$66K
Nov 14, 2024	John Aballi President & CEO	Bought	24,305	$2.81	$68K